Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer
ACTIVE_NOT_RECRUITING
Status
Conditions
- Lung Non-Small Cell Carcinoma
- Stage I Lung Cancer AJCC v8
- Stage II Lung Cancer AJCC v8
Interventions
- DRUG: Atezolizumab
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Computed Tomography
- OTHER: Fludeoxyglucose F-18
- PROCEDURE: Positron Emission Tomography
- OTHER: Quality-of-Life Assessment
- OTHER: Questionnaire Administration
- RADIATION: Stereotactic Body Radiation Therapy
Sponsor
National Cancer Institute (NCI)